Abstract
Background
Both gastroesophageal reflux disease and allergy/atopy have been implicated in the pathogenesis of eosinophilic esophagitis (EoE). There are no prospective studies comparing treatment of EoE with acid suppression versus topical corticosteroids.
Objective
To determine the outcome of adult eosinophilic esophagitis patients treated with esomeprazole versus topical fluticasone.
Design
Prospective randomized controlled trial.
Setting
Academic medical center.
Participants
Adults (18–80) diagnosed with EoE by symptoms of dysphagia and esophageal biopsies with ≥15 eosinophils/hpf.
Interventions
Subjects were randomized to esomeprazole (40 mg by mouth every morning) or aerosolized, swallowed fluticasone (440 mcg by mouth twice a day) for 8 weeks.
Main Outcome Measurements
Improvement in dysphagia (8-point scale), esophageal eosinophil infiltration before and after treatment, prevalence of GERD measured by validated questionnaire and baseline pH study.
Results
About 56% (14/25) had acid reflux by pH study. There was no difference between treatment groups in improvement in dysphagia scores [3/12 (25%) of the esomeprazole group versus 6/12 (50%) in the fluticasone group, P = 0.40]. Eosinophil infiltration decreased with treatment in both groups, and there was no difference in the amount of decrease between groups (P = 0.70).
Limitations
Small sample size, unexpectedly high drop-out rate.
Conclusions
Gastroesophageal reflux disease is common in adult eosinophilic esophagitis patients. Dysphagia improves and esophageal eosinophilic infiltration decreases with either treatment. There was no difference in degree of improvement in dysphagia or eosinophil infiltration in patients treated with either topical fluticasone or oral esomeprazole. GERD may be important in the pathogenesis of adult EoE.
Similar content being viewed by others
References
Furuta G, Licouras C, Collins M, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133:1342–1363. doi:10.1053/j.gastro.2007.08.017.
Liacouras C. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr. 2003;37(Suppl 1):S23–S28.
Orebaugh H, Peterson K, Kuwada S, Fang J. Ringed esophagus is associated with atopy not GERD. Gastroenterology. 2003;124:A235. doi:10.1016/S0016-5085(03)81181-2.
Fox V, Nurko S, Furuta G. Eosinophilic esophagitis: it’s not just kid’s stuff. Gastrointest Endosc. 2002;56:260–270. doi:10.1016/S0016-5107(02)70188-0.
Straumann A, Spichtin H, Grize L, Bucher K, Beglinger C, Simon H. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology. 2003;125:1660–1669.
Spergel J, Andrews T, Brown-Whitehorn T, Beausoleil J, Liacouras CA. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol. 2005;95:336–343.
Sant’Anna A, Rolland S, Fournet J, Yazbeck S, Drouin E. Eosinophilic esophagitis in children: symptoms, histology and pH probe results. J Pediatr Gastroenterol Nutr. 2004;39:373–377. doi:10.1097/00005176-200410000-00013.
Orenstein S, Shalaby T, Lorenzo C, Putnam P, Sigurdsson L, Kocochis S. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 patients. Am J Gastroenterol. 2000;95(6):1422–1430.
Teitelbaum J, Fox V, Twarog F, et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone proprionate. Gastroenterology. 2002;122:1216–1225. doi:10.1053/gast.2002.32998.
Attwood S, Lewis C, Bronder C, Morris C, Armstrong G, Whittam J. Eosinophilic oesophagitis: a novel treatment using montelukast. Gut. 2003;52(8):1228–1229.
Remedios M, Campbell C, Jones D, Kerlin P. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63:3–12. doi:10.1016/j.gie.2005.07.049.
Lucendo A, Pascual Turrion JM, Navarro M, et al. Endoscopic, bioptic, and manometric findings in eosinophilic esophagitis before and after steroid therapy: a case series. Endoscopy. 2007;39:765–771. doi:10.1055/s-2007-966738.
Langdon D. Fluticasone in eosinophilic corrugated ringed esophagus. Am J Gastroenterol. 2001;96(3):926–927.
Konikoff M, Noel R, Blanchard C, et al. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 2006;131:1381–1391. doi:10.1053/j.gastro.2006.08.033.
Arora A, Perrault J, Smyrk T. Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults. Mayo Clin Proc. 2003;78:830–835. doi:10.4065/78.7.830.
Faubion W, Perrault J, Burgart L, Zein N, Clawson M, Freese D. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr. 1998;27(1):118–119.
Morrow J, Vargo J, Goldblum J, Richter J. The ringed esophagus: histological features of GERD. Am J Gastroenterol. 2001;96:984–989. doi:10.1111/j.1572-0241.2001.03682.x.
Ngo P, Furuta G, Antonioli D, Fox V. Eosinophils in the esophagus—Peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101:1666–1670. doi:10.1111/j.1572-0241.2006.00562.x.
DiSario J, Pedersen P, Bichis-Canoutas C, Alder S, Fang J. Incision of recurrent distal esophageal (Schatzki) ring after dilation. Gastrointest Endosc. 2002;56:244–248. doi:10.1016/S0016-5107(02)70185-5.
Aanen M, Numens M, Wusten B, Smout A. Diagnostic value of the reflux disease questionnaire in general practice. Digestion. 2006;74:162–168.
Emerson L, Tripp S, Baird B, Layfield L, Rohr L. A comparison of immunohistochemical stain quality in conventional and rapid microwave processed tissues. Am J Clin Pathol. 2006;125:176–183.
Wills J, Hilden K, DiSario J, Fang J. A randomized, prospective trial of electrosurgical incision followed by rabeprazole versus bougie dilation followed by rabeprazole of symptomatic esophageal (Schatzki’s) rings. Gastrointest Endosc. 2008;67:808–813. doi:10.1016/j.gie.2007.10.062.
Brown L, Goldman H, Antonioli D. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol. 1984;8:899–905. doi:10.1097/00000478-198412000-00002.
Tummala V, Barwick K, Sontag S, Vlahsevic R, McCallum R. The significance of intraepithelial eosinophils in the histologic diagnosis of gastroesophageal reflux. Am J Clin Pathol. 1987;87:43–48.
Gupta S, Fitzgerald J, Kondratyuk T, HogenEsch H. Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:22–26. doi:10.1097/01.mpg.0000188740.38757.d2.
Steiner S, Gupta S, Croffie J, Fitzgerald J. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring. Am J Gastroenterol. 2004;99:801–805. doi:10.1111/j.1572-0241.2004.04170.x.
Steiner S, Kernek K, Fitzgerald J. Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2006;42:506–509. doi:10.1097/01.mpg.0000221906.06899.1b.
Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao M, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313–319. doi:10.1016/j.gie.2006.04.037.
Coen A, Petersen K, Clark H, Moore E, Hilden K, Fang J. Prevalence of GERD and allergy in eosinophilic esophagitis. Gastroenterology. 2004;126:A447.
Spechler S, Genta R, Souza R. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol. 2007;102:1301–1306. doi:10.1111/j.1572-0241.2007.01179.x.
Calabrese C, Bortolotti M, Fabbri A, et al. Reversibility of GERD ultrastructual alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol. 2005;100:537–542. doi:10.1111/j.1572-0241.2005.40476.x.
Caviglia R, Ribolsi M, Gentile M, et al. Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;25:629–636.
Mishra A, Hogan S, Brandt E, Rothenberg M. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest. 2001;107:83–90. doi:10.1172/JCI10224.
Aceves S, Bastian J, Newbury R, Dohil R. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol. 2007;102:2271–2279. doi:10.1111/j.1572-0241.2007.01379.x.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding support was provided in part by an ASGE Research grant.
Rights and permissions
About this article
Cite this article
Peterson, K.A., Thomas, K.L., Hilden, K. et al. Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis. Dig Dis Sci 55, 1313–1319 (2010). https://doi.org/10.1007/s10620-009-0859-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-009-0859-4